181130 Teratogen Information Specialists: Working with Clinicians to Promote Healthy Mothers and Babies

Wednesday, October 29, 2008: 11:10 AM

Christina D. Chambers, PhD, MPH , Department of Pediatrics and Family and Preventive Medicine, University of California San Diego, La Jolla, CA
An important component of preconception and prenatal care is access to accurate and individualized risk counseling regarding potentially teratogenic exposures to medications, chemicals, street drugs, alcohol and tobacco. However, it is difficult for health care providers to maintain up-to-date knowledge in this specialty area and/or to devote the time necessary to communicate this information to their patients in a personalized and comprehensive manner. In response to this public health need, since the late 1970's, more than 15 Teratology Information Services have been established in the U.S. and Canada. These Services, known collectively as the Organization of Teratology Information Specialists (OTIS), are comprised of hospital and university-based units who provide toll-free telephone counseling and referral to over 70,000 health care provider and patient callers per year. OTIS services routinely help reduce patient anxiety while aiding the clinician and the patient in making optimum choices regarding necessary treatments during pregnancy and lactation. In addition, during public health crisis situations, such as Hurricane Katrina, OTIS services have been able to respond to the unique concerns that arise in the special population of pregnant women. Increased awareness of and utilization of OTIS services can complement obstetric health care practice.

Learning Objectives:
1. Recognize the purpose and value of Teratology Information Services in supporting clinical obstetric practice 2. Describe the services provided by Teratology Information Specialists in the U.S. and Canada 3. Define how teratology information services can help prevent birth defects and other adverse pregnancy outcomes in patients who are or who may become pregnant

Keywords: Birth Defects, Prenatal Care

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I am the Director of a Teratology Information Service and the past president of the North American Organization of Teratology Information Specialists
Any relevant financial relationships? Yes

Name of Organization Clinical/Research Area Type of relationship
Abbott Laboratories medications in pregnancy Independent Contractor (contracted research and clinical trials)
Amgen/Immunex medications in pregnancy Independent Contractor (contracted research and clinical trials)
Barr Labs medications in pregnancy Independent Contractor (contracted research and clinical trials)
Apotex medications in Pregnancy Independent Contractor (contracted research and clinical trials)
Bristol Myers Squibb Medications in Pregnancy Independent Contractor (contracted research and clinical trials)
Hoffman La Roche medications in pregnancy Independent Contractor (contracted research and clinical trials)
Kali Labs medications in pregnancy Independent Contractor (contracted research and clinical trials)
Teva medications in pregnancy Independent Contractor (contracted research and clinical trials)
Sandoz medications in pregnancy Independent Contractor (contracted research and clinical trials)
Sanofi Aventis medications in pregnancy Independent Contractor (contracted research and clinical trials)
Sanofi-Pasteur vaccines in pregnancy Independent Contractor (contracted research and clinical trials)

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.